Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross Hamblin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Archives of Medical Research|November 20, 2023
Impulse Control Disorders in Patients with Pituitary Tumors Treated with Dopamine Agonists: A Systematic ReviewRoss Hamblin, Niki Karavitaki
Best Practice & Research. Clinical Endocrinology & Metabolism|April 25, 2026
Impulse control disorders and dopamine agonistsRoss Hamblin, Georgia Ntali, Niki Karavitaki
Presse Medicale (Paris, France : 1983)|October 24, 2021
CraniopharyngiomasRoss Hamblin, Georgios Tsermoulas, Niki Karavitaki
Journal of Neuroendocrinology|May 1, 2022
The diagnosis and management of Cushing's syndrome in pregnancyRoss Hamblin, Amy Coulden, Athanasios Fountas, et al.
Pituitary|July 22, 2022
Cardiovascular health and mortality in Cushing's diseaseAmy Coulden, Ross Hamblin, John Wass, et al.
Pituitary|November 26, 2022
UK practice on incidentally detected non-functioning pituitary microadenomas: analysis of two national surveys during a 12-year intervalRoss Hamblin, Athanasios Fountas, Miles Levy, et al.
Pituitary|April 21, 2025
Impulse control disorders in patients with pituitary adenoma managed with or without dopamine agonists: a cross-sectional study from a UK centreRoss Hamblin, Mary White, Athanasios Fountas, et al.
The Lancet. Diabetes & Endocrinology|July 5, 2022
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillanceRoss Hamblin, Ashley Vardon, Josephine Akpalu, et al.
European Journal of Endocrinology|June 22, 2023
Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortiumRoss Hamblin, Athanasios Fountas, Kirstie Lithgow, et al.
European Journal of Endocrinology|April 30, 2025
Conservatively managed non-functioning pituitary macroadenomas-cohort study from the UK Non-functioning Pituitary Adenoma ConsortiumAthanasios Fountas, Kirstie Lithgow, Paul Benjamin Loughrey, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Archives of Medical Research|November 20, 2023
Impulse Control Disorders in Patients with Pituitary Tumors Treated with Dopamine Agonists: A Systematic ReviewRoss Hamblin, Niki Karavitaki
Best Practice & Research. Clinical Endocrinology & Metabolism|April 25, 2026
Impulse control disorders and dopamine agonistsRoss Hamblin, Georgia Ntali, Niki Karavitaki
Presse Medicale (Paris, France : 1983)|October 24, 2021
CraniopharyngiomasRoss Hamblin, Georgios Tsermoulas, Niki Karavitaki
Journal of Neuroendocrinology|May 1, 2022
The diagnosis and management of Cushing's syndrome in pregnancyRoss Hamblin, Amy Coulden, Athanasios Fountas, et al.
Pituitary|July 22, 2022
Cardiovascular health and mortality in Cushing's diseaseAmy Coulden, Ross Hamblin, John Wass, et al.
Pituitary|November 26, 2022
UK practice on incidentally detected non-functioning pituitary microadenomas: analysis of two national surveys during a 12-year intervalRoss Hamblin, Athanasios Fountas, Miles Levy, et al.
Pituitary|April 21, 2025
Impulse control disorders in patients with pituitary adenoma managed with or without dopamine agonists: a cross-sectional study from a UK centreRoss Hamblin, Mary White, Athanasios Fountas, et al.
The Lancet. Diabetes & Endocrinology|July 5, 2022
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillanceRoss Hamblin, Ashley Vardon, Josephine Akpalu, et al.
European Journal of Endocrinology|June 22, 2023
Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortiumRoss Hamblin, Athanasios Fountas, Kirstie Lithgow, et al.
European Journal of Endocrinology|April 30, 2025
Conservatively managed non-functioning pituitary macroadenomas-cohort study from the UK Non-functioning Pituitary Adenoma ConsortiumAthanasios Fountas, Kirstie Lithgow, Paul Benjamin Loughrey, et al.
Pageof 1